Standard-Free Absolute Quantitation of Antibody Deamidation Degradation and Host Cell Proteins by Coulometric Mass Spectrometry.
Standard-Free Absolute Quantitation of Antibody Deamidation Degradation and Host Cell Proteins by Coulometric Mass Spectrometry.
复制标题
DOI:
10.1021/acs.analchem.2c02709
复制
发表时间:
2022-09-13
影响因子:
7.4
通讯作者:
Chen, Hao
中科院分区:
文献类型:
--
作者:
Ai, Yongling;Gunawardena, Harsha P.;Li, Xuanwen;Kim, Yong-Ick;Dewald, Howard D.;Chen, Hao
Proteomic absolute quantitation strategies mainly rely on the use of synthetic stable isotope-labeled peptides or proteins as internal standards, which are highly costly and time-consuming to synthesize. To circumvent this limitation, we recently developed a coulometric mass spectrometric (CMS) approach for absolute quantitation of proteins without the use of standards, based on the electrochemical oxidation of oxidizable surrogate peptides followed by mass spectrometric measurement of the peptide oxidation yield. Previously, CMS was only applied for single protein quantitation. In this study, first, we demonstrated absolute quantitation of multiple proteins in a mixture (e.g., β-lactoglobulin B, α-lactalbumin and carbonic anhydrase) by CMS in one run, without using any standards. The CMS quantitation result was validated with traditional isotope dilution method. Second, CMS can be used for absolute quantitation of low-level target protein in mixture; for instance, 500 ppm of PLBL2, a problematic host cell protein (HCP), in the presence of highly dominant monoclonal antibody (mAb) was successfully quantified by CMS with no use of standards. Third, taking one step further, this study conducted the unprecedented quantitative analysis of deamidated peptide products arising from mAb heavy chain deamidation reaction. In particular, the deamidation succinimide intermediate which had not been measured before due to lack of standard was quantified by CMS, for the first time. Overall, our data suggest that CMS has unique potential utilities for quantitative proteomics and for biotherapeutic drug discovery.
登录
查看更多内容
影响因子:
3.8
作者:
Cao, Mingyan;Xu, Weichen;Wang, Jihong
通讯作者:
Wang, Jihong
影响因子:
3.8
作者:
Gupta, Surbhi;Jiskoot, Wim;Rathore, Anurag S.
通讯作者:
Rathore, Anurag S.
影响因子:
4.4
作者:
Hains, Peter G.;Truscott, Roger J. W.
通讯作者:
Truscott, Roger J. W.
影响因子:
2.3
作者:
Liigand, Piia;Kaupmees, Karl;Kruve, Anneli
通讯作者:
Kruve, Anneli
DOI:
10.1021/jasms.1c00121
发表时间:
2021-07-07
影响因子:
3.2
作者:
Ai Y;Zhao P;Fnu PIJ;Chen H
通讯作者:
Chen H